How Does Zepbound Work? GLP-1 and GIP Explained Simply

Written by Nataliia Bondarchuk. Updated October 23, 2026.

Zepbound works by copying two hormones your gut releases after you eat, GLP-1 and GIP. Together they tell your brain you are full, slow down your stomach, and help your body handle sugar and fat better. The result is that you eat less without feeling as hungry, and over a year or more most people lose a large amount of weight: about 21% of their body weight at the highest dose in the main trial.

That is the one-paragraph version. Here is what is actually happening inside your body after each weekly injection, why Zepbound tends to beat older drugs like Wegovy, and what the mechanism means for side effects and for what happens when you stop.

After a meal, cells in your gut release several hormones that signal "food has arrived." Two of the most important are GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Both tell the pancreas to release insulin and send fullness signals to the brain. Your own versions are broken down within minutes.

Older weight-loss injections such as Wegovy and Ozempic copy only GLP-1. Tirzepatide was engineered to activate both the GLP-1 and the GIP receptor and to last about five days in the blood instead of a few minutes. Lilly calls it a dual GIP and GLP-1 receptor agonist. The GIP part is what sets it apart, and researchers think GIP adds extra appetite suppression and better fat handling while also easing some of the nausea that GLP-1 alone causes.

Put simply, Zepbound makes a calorie deficit feel normal. In the SURMOUNT-1 trial, people who took 15 mg a week for 72 weeks lost an average of 20.9% of their body weight, compared with 3.1% on placebo. Even the lowest maintenance dose, 5 mg, produced about 15% loss. More than half of people on the top dose lost at least 20%. For someone starting at 230 pounds, that is roughly 48 pounds.

Weight loss comes mainly from eating less. Studies that measured food intake found people on tirzepatide ate several hundred fewer calories a day without being told to. The drug does not raise your metabolism, and it does not target belly fat specifically, although visceral fat tends to fall as total weight does. For a week-by-week picture, see tirzepatide weight loss by week, and for the dose-by-dose numbers, tirzepatide dosage for weight loss.

Zepbound begins at 2.5 mg for four weeks, then rises in 2.5 mg steps to a maintenance dose of 5, 10 or 15 mg. The 2.5 mg dose is not meant to cause much weight loss; it lets your stomach and gut adjust so nausea stays manageable. This is also why Zepbound takes a few months to show its full effect, and why stopping and restarting usually means going back to a lower dose.

Because it works on two receptors, Zepbound has produced more weight loss than semaglutide (Wegovy) in trials. In the SURMOUNT-5 head-to-head study, people on tirzepatide lost about 20% of their body weight versus about 14% on semaglutide 2.4 mg over 72 weeks. The newer Wegovy HD 7.2 mg dose narrows that gap. Side effects are similar and mostly digestive. We go through the numbers in tirzepatide vs semaglutide.

Zepbound and Mounjaro are the same drug under two names: Mounjaro is approved for type 2 diabetes and Zepbound for weight management and sleep apnea. See Mounjaro vs Zepbound.

Most Zepbound side effects follow directly from how it works:

Zepbound does not reset your appetite permanently. Once the drug leaves your body, about four to five weeks after the last dose, hunger returns. In the SURMOUNT-4 trial, people who switched to placebo after 36 weeks regained about 14% of their body weight over the next year, while those who kept taking tirzepatide lost a further 5.5%. That is why it is approved for long-term use. Our guide to what happens when you stop tirzepatide covers how to plan for it.

A note on devices: if you use the new multi-dose pen, a missed priming step or an incomplete dose can quietly cut what you receive. Our Zepbound KwikPen guide explains the dose-check steps.

If you have been offered "tirzepatide peptide" from a non-pharmacy source, it is worth understanding what the word means and does not mean; is tirzepatide a peptide explains the chemistry and why it is nothing like the research peptides sold online.

Zepbound is often confused with other weight-loss brands. Our guide is Wegovy tirzepatide? maps each brand name to its active ingredient.

Zepbound is also FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity. We cover the SURMOUNT-OSA results, CPAP and Medicare coverage in Zepbound for sleep apnea.

Zepbound works by mimicking two gut hormones, GLP-1 and GIP, that lower appetite, slow digestion and improve how your body handles sugar and fat. The combination explains both its strong results, about 15% to 21% weight loss depending on dose, and its mostly digestive side effects. It is a tool that makes eating less feel natural, not a drug that burns fat on its own, and it keeps working only while you keep taking it.

This article is for general information and is not medical advice. Talk to your doctor before starting or stopping any weight-loss medicine.